Why is PLSE up?
Up 209% in a year while the S&P 500 rose 12%.
- Its filed figures weakened while the shares beat the market.
PLSE's Quality Score rose 1 point on Mon, Nov 2, to 9. Trading was quieter than usual.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
Up 209% in a year while the S&P 500 rose 12%.
| The chart | Stronger than 99% of stocks |
| Latest filing | 424B5, Sep 15 |
ReportReports Thursday, after the close. Every 3 months, a company tells everyone how much it sold and earned. It fell after 3 of its last 4 reports, -2.7% on average. Past reports ›
Thu Nov 12: Stifel Healthcare Conference 2026Investor conference · date confirmed.
After its last 4 reports it closed -2.7% on average, higher 1 of 4 times.
Averagefor quality, not price, 6 of 14 chart checks firingWhat the Quality Score means
PLSE is #23 of 85 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 23 |
Reports Thu Nov 5, after the close (in 3 days). Confirmed.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 6, 2026 | -1.1% | +10.9% | +17.5% |
| May 4, 2026 | -1.6% | -3.8% | -8.4% |
| Feb 19, 2026 | -2.5% | -14.6% | -23.1% |
Sales grew in two of the last five years, to $350K in 2025. It lost money in each of the six years.
3 insiders bought $13.5M across 6 filings in the last 6 months. No open-market sales on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: PLSE is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Pulse Biosciences Inc is a novel bioelectric medicine company committed to health innovation using its patented Nano-Pulse Stimulation technology, a revolutionary energy modality that delivers nanosecond-duration pulses of electrical energy, each less than a millionth of a second long, to non-thermally clear targeted cells while sparing adjacent noncellular tissue. NPS technology, also referred to as Nanosecond Pulsed Field Ablation (nsPFA) technology delivers nanosecond pulses of electrical energy to nonthermally clear cells while sparing adjacent noncellular tissue.
“Our medical products and products under development are for applications that are constantly under pressure from intense competition from rapidly evolving companies and new scientific discoveries.”
PLSE scores 9 today, which Breakaway calls Average. It is #23 of 85 in Medical Devices by Quality Score, with 6 of 14 chart checks firing. Up 209% in a year while the S&P 500 rose 12%. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
PLSE scores 9 today, which Breakaway calls Average (6 to 10). That is #23 of 85 in Medical Devices by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind PLSE's 9.
3 insiders bought $13.5M across 6 filings in the last 6 months. No open-market sales on record. The newest is Liane Rae Teplitsky, Chief Operating Officer, who bought $50K on Sep 1. Every filing, with the scored weight, for Pro members.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.